Why IDP Education, Novonix, PYC, and Regis Resources share are racing higher

These shares are ending the week strongly. Here's what you need to know.

| More on:
Woman looks amazed and shocked as she looks at her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. In afternoon trade, the benchmark index is up 0.4% to 7,853.5 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

IDP Education Ltd (ASX: IEL)

The IDP Education share price is up 4.5% to $15.16. Bargain hunters have been buying the language testing and student placement company's shares after they were sold off again this week following a poor update. Analysts at Goldman Sachs think investors should be snapping them up while they are down. This morning, the broker reiterated its buy rating with a trimmed price target of $21.75. This implies potential upside of over 40% for investors from current levels.

Novonix Ltd (ASX: NVX)

The Novonix share price is up almost 8% to 69.5 cents. This morning, this battery materials company returned from a trading halt after denying that it is planning to launch a capital raising in the near future. Management stated that its capital position is strong and one is not required. It said: "NOVONIX Limited refers to the article published in the Australian Financial Review speculating that NOVONIX will undertake a capital raising. NOVONIX wishes to advise that it has considered its position and is not undertaking an equity capital raising at this time and that its capital position remains strong."

PYC Therapeutics Ltd (ASX: PYC)

The PYC Therapeutics share price is up 10% to 11 cents. Investors have been buying the clinical-stage biotechnology company's shares after an update on its drug discovery program, which is directed towards a severe neurodevelopmental disorder known as Phelan McDermid Syndrome (PMS). It notes that PMS is caused by a loss of one functional copy of the SHANK3 gene, resulting in insufficient SHANK3 protein expression in brain cells known as neurons. This morning, PYC revealed that it has been able to restore the missing SHANK3 protein. The company will now progress towards initiating the studies required to enter human trials. This is anticipated to commence in 2025.

Regis Resources Ltd (ASX: RRL)

The Regis Resources share price is up 3.5% to $1.92. Investors have been buying Regis Resources and other ASX gold shares today after the precious metal charged to a two-week high overnight on rate cut hopes. This has led to the S&P/ASX All Ordinaries Gold index outperforming on Friday afternoon with a 1.7% gain.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Idp Education. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A man holds his head in his hands after seeing bad news on his laptop screen.
Share Gainers

These were the worst-performing ASX 200 shares in January

Investors were selling off these shares in January. But why?

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

These were the best-performing ASX 200 shares in January

Let's see why investors were bidding these shares higher during the month.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a tough end to the trading week for investors this Friday.

Read more »

Three trophies in declining sizes with a red curtain backdrop.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

Investors have sent these three ASX 200 stocks surging ahead of the benchmark this week.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Share Gainers

Why 4DMedical, Appen, Nine Entertainment, and ResMed shares are storming higher today

These shares are ending the week on a positive note. But why?

Read more »

A young man wearing glasses and a denim shirt sits at his desk and raises his fists and screams with delight.
Technology Shares

Appen share price surging 67% since Wednesday. Here's why

ASX investors have lit a fuse under the Appen share price. But why?

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Appen, Imricor, Sunrise Metals, and Whitehaven Coal shares are charging higher today

These shares are avoiding the market weakness on Thursday. But why?

Read more »

A man cheers after winning computer game, while woman sitting next to him looks upset.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were happy today... until the inflation data came out.

Read more »